VIEW ALL SEARCH RESULTS
Type in Product Names, Product Numbers, or CAS Numbers to see suggestions.
Sigma-Aldrich Corporation (NASDAQ: SIAL) is pleased to announce that the Cerilliant® brand within its Applied Diagnostics and Testing business is introducing eight new Certified Spiking Solutions® of tryptamines for use in quantitative mass spec-based testing applications such as forensic analysis, clinical toxicology, urine drug testing, or pharmaceutical research. This product introduction includes solution CRMs for five synthetic tryptamines 5-MeO-AMT, 5-MeO-DALT, 5-MeO-MiPT, 5-MeO-DMT, and 5-MeO-DiPT in addition to three naturally occurring tryptamines N, N-dimethyltryptamine; psilocybin; and its stable-labeled internal standard.Read More
Sigma-Aldrich® Corporation (NASDAQ: SIAL) today announced that Sigma Life Science, its innovative biological products and services business, released Next-Gen Sequencing Oligos, custom next-generation sequencing adapters that improve target sequence assembly. These oligos are expected to allow researchers to achieve better results from multiplexing experiments.Read More
硝酸銀キャンペーン (318KB PDF)
MISSION LentiPlexキャンペーン(710KB PDF)
TLCプレート30%OFF キャンペーン(1.2MB PDF)
Merck KGaA, a leading company for innovative and top-quality high-tech products in the pharmaceutical, chemical and life science sectors, and Sigma-Aldrich today announced that they have entered into a definitive agreement under which Merck KGaA, Darmstadt, Germany, will acquire Sigma-Aldrich for $17.0 billion (€13.1 billion), establishing one of the leading players in the $130 billion global life science industry.Read More